Financials
- Market Capitalization 51.08 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.33
売上高対価格比率
664.32
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4280 | TIL Instil Bio, Inc. - Common Stock | 7.93 USD | +3.80% | +2.19% | -0.25% | -59.31% | 53.78 M USD | ||
| 4281 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.03 USD | -2.27% | -1.42% | +13.02% | +1154.17% | 52.22 M USD | ||
| 4295 | TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.06 USD | -0.96% | -0.96% | -13.08% | -22.82% | 50.31 M USD | ||
| 4300 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.35 USD | +2.27% | +7.14% | +10.66% | -6.25% | 50.82 M USD |